Compare NOV Inc. Common Stock (NOV) vs Novavax Inc (NVAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NOV Inc. Common Stock vs Novavax Inc — how do they compare? NOV Inc. Common Stock trades at $19.08 (market cap $6.64B), while Novavax Inc trades at $11 (market cap $1.85B). The key difference: NOV Inc. Common Stock is far larger — about 3.6× Novavax Inc's market cap, and NOV Inc. Common Stock pays a 1.93% dividend while Novavax Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold NOV Inc. Common Stock for 0 Days and Novavax Inc for 59 Days on average.
| NOV | NVAX | |
|---|---|---|
Market Cap | $6.64B | $1.85B |
Volume | 4,238,905 | 8,362,562 |
Sector | Energy | Health |
52-Week High | $21.71 | $12.56 |
52-Week Low | $12.31 | $6.22 |
Typical Hold Time | 0 Days | 59 Days |
Enterprise Value | $7.80B | $1.43B |
Dividend Yield | 1.93% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Novavax (NVAX) trades at $11.01, down 2.74% on the day, with a mixed technical picture showing bullish moving averages but neutral oscillators. The company reported strong revenue of $1.12B in 2025 with a net income of $440.30M, though 2026 projections show a return to losses. Recent news highlights the company's pivot to a partnership-driven model using its Matrix-M adjuvant technology, with regulatory approvals for its updated COVID-19 vaccine in major markets.
Investment outlook remains speculative with analyst consensus heavily favoring Buy ratings (73.92%) but fundamental risks persist including negative cash flow trends and high debt levels. The stock offers potential upside from partnership expansions but faces significant execution and competitive risks in the biopharma sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NOV Inc. Common Stock
NOV provides technology, equipment, and services for energy production. Its offerings support drilling, well construction, and production across oil, gas, renewables, and emerging energy markets.
Read more on NOV →About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →
